Stenoparib, an inhibitor of cellular poly (ADP-ribose) polymerases (PARPs), blocks in vitro replication of SARS-CoV-2 variants
Author(s) -
Katherine E. Zarn,
Sierra A. Jaramillo,
Anthony R. Zapata,
Nathan E. Stone,
Ashley Jones,
Haley E. Nunnally,
Erik W. Settles,
Ken Ng,
Paul Keim,
Steen Knudsen,
Patricia M. Nuijten,
Aloys S. L. Tijsma,
Christopher T. French
Publication year - 2022
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0272916
Subject(s) - polymerase , poly adp ribose polymerase , in vitro , viral replication , biology , strain (injury) , replication (statistics) , beta (programming language) , virology , microbiology and biotechnology , chemistry , enzyme , virus , biochemistry , anatomy , computer science , programming language
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom